Video Gallery

Video Gallery

To View the Video

Curettage, Adjuvants, and Artificial Bone Grafting for Management of Giant Cell Tumor of Bone

March 01, 2020

Contributors: Katsuhiro Hayashi, MD; Takashi Higuchi, MD; Sei Morinaga, MMED (Ortho); Akihiko Takeuchi, MD; Hiroyuki Tsuchiya, MD; Hirotaka Yonezawa, MD; Norio Yamamoto, MD

2020 AWARD WINNER Giant cell tumors of bone are histologically benign but locally aggressive osteolytic lesions. Giant cell tumors of bone arise in the metaphyseal region of long bones, predominantly the distal femur and the proximal tibia. Giant cell tumors of bone occur in young adults and skeletally mature adolescents. The tumors occur in females slightly more often than males. Giant cell tumors of bone account for 5% of all bone tumors and 20% of benign bone tumors. Local recurrence is a major challenge encountered during the clinical management of giant cell tumors of bone. Surgical treatment options include curettage with or without adjuvant therapy and wide resection with biologic or nonbiologic reconstruction. This video demonstrates our surgical technique for the management of a giant cell tumor of bone.

Results for "Musculoskeletal Oncology"

2 of 5
2 of 5

X